News & Updates

Treatment with trastuzumab emtansine (T-DM1) plus tucatinib safely prolongs progression-free survival (PFS) in patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC), including those with brain metastases, reports a study.

Breast cancer survivors who have adequate sleep achieve greater benefits from behavioural weight loss (BWL) intervention than those with poor sleep, according to the results from the POWER-Remote trial.

Never smokers with selected risk factors who undergo lung cancer screening may show similar detection rates to high-risk ever smokers or even higher rates when compared with unselected never smokers, reveals a Singapore study.

Metronomic chemotherapy has emerged as an effective treatment option with low toxicity for elderly and unfit patients. In an interview with MIMS Oncology, Dr Ashley Cheng, Specialist in Clinical Oncology in private practice in Hong Kong, discussed use of metronomic oral vinorelbine (m-OV) in frail patients with advanced non-small-cell lung cancer (NSCLC) and highlighted its advantages, including convenience and favourable tolerability.

A randomized, double-blind, placebo-controlled trial from Iran reports a significant reduction in frequency of mild hot flushes with use of melatonin in patients with prostate cancer (PC) undergoing androgen deprivation therapy (ADT).